GATIPOTUZUMAB
UNII 85V55ZLV2Z

Substance Identification & Data

This profile provides standardized clinical and technical data for Gatipotuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 85V55ZLV2Z.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1264737-26-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

85V55ZLV2Z

CAS Registry Number

1264737-26-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

GATIPOTUZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C94220

National Cancer Institute reference terminology for clinical and research data.

INN ID

10336

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Gatipotuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GATIPOTUZUMAB

Common Names & Synonyms

GATIPOTUZUMAB [INN]

GATIPOTUZUMAB [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(MUCIN MUC1) (HUMAN-MUS MUSCULUS MONOCLONAL PANKOMAB-GEX HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL PANKOMAB-GEX LIGHT CHAIN, DIMER

External Clinical & Regulatory Resources

Previous UNII85V4R482M3

Next UNII85V68HK5C4